期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心力衰竭部分药物治疗的循证医学新进展 被引量：16

下载PDF
导出
摘要 近年来,对慢性心力衰竭的治疗研究不断进步,一些新的药物临床试验给治疗带来希望:重组B型利钠肽可以改善患者的临床症状,提高生活质量,不影响肾功能,但对长期预后无良性影响;左西孟旦对慢性心力衰竭急性加重者可改善血流动力学参数,缓解临床症状,但对长期生存率的改善无明显证据;托伐普坦能改善患者的临床症状,对肾功能无不良影响,但长期生存率和死亡率无明显改善;他汀类药物从理论上讲应该可以改善患者的长期生存率和死亡率,但目前的临床证据尚无法统一结论;阿利吉仑可能会对患者的长期病死率产生良性影响,改善预后。该文从这5种药物的循证医学方面就慢性心力衰竭药物治疗的最新研究进展简要综述。
作者 黄俊玲 罗明
机构地区 同济大学附属同济医院心血管内科
出处 《国际心血管病杂志》 2011年第1期30-33,共4页 International Journal of Cardiovascular Disease
关键词 心力衰竭 循证医学 B型利钠肽 左西孟旦 托伐普坦 他汀类药物 阿利吉仑
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献25

  • 1Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology[J].. Eur Heart J, 2005, 26(4) :384- 416.
  • 2Yancy CW, Sahzberg MT, Berkowitz RL, etal. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting ( from the FUSION I trial) [J]. AmJ Cardioh 2004, 94(5) 595-601.
  • 3Yancy CW, Singh A. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency ( from the Follow Up Serial Infusions of Nesiritide [ FUSION I] trial) [J]. Am J Cardiol,2006, 98 (2) 226-229.
  • 4Yancy CW, Krum H, Massie BM, et al. The Second Follow up Serial Infusions of Nesiritide ( FUSION II ) trial for advanced heart failure: study rationale and design[J]. Am Heart J, 2007, 153(4) 478- 484.
  • 5Hernandez AF, O'Connor CM, Starling RC,et al. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCENI> HF) [J]. Am Heart J, 2009, 157(2): 271- 277.
  • 6Kivikko M, Lehtonen L. Levosimendan: A new inodilatory drug for the teatment of decompensated heart failure [J].Curr Pharm Des, 2005, 11(4) : 435-455.
  • 7Braun JP, Jasulaitis D, Moshirzadeh M, et al. Levosimendan may improve survival in patients requiring meehnical assist devices for post-cardiotomy heart failure [J].Crit Care, 2006, 10(1) R17.
  • 8Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patientswith acute decompensated heart failure: the SURVIVE Randomized Trial[J].JAMA, 2007, 297(17) : 1883- 1891.
  • 9Delaney A, Bradford C, MeCaffrey J, et al. Levosimendan for the treatment of acute severe heart failure: A meta analysis of randomised controlled trials [J].Int J Cardiol,2010,138(3): 281-289.
  • 10黄震华.伴有低钠血症的心力衰竭的治疗进展[J].中国新药与临床杂志,2008,27(5):384-387. 被引量：13

二级参考文献14

  • 1OREN RM. Hyponatremia in congestive heart failure[J]. Am J Cardiol, 2005, 95(9A) : 2B-7B.
  • 2ADROGUE HJ, MADIAS NE. Hyponatremia[J]. N Engl J Med, 2000, 342(21) : 1581-1589.
  • 3LEE CR, WATKINS ML, PATTERSON JH, et al. Vasopressin:a new target for the treatment of heart failure[J]. Am Heart J, 2003, 146(1): 9-18.
  • 4CHEN MC, CHANG HW, CHENG CI, et al. Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy[J]. Cardiology, 2003, 100(3): 136-142.
  • 5GOLDSMITH SR. Current treatment and novel pharmacologic treatments for hyponatremia in congestive heart failure[J]. Am J Cardiol, 2005, 95(9A): 14B-23B.
  • 6LICATA G, DI PASQUALE P, PARRINELLO G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects[J]. Am Heart J, 2003, 145(3): 459-466.
  • 7HIRANO T, YAMAMURA Y, NAKAMURA S, et al. Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats[J]. J Pharmacol Exp Ther, 2000, 292(1): 288-294.
  • 8CHATTERJEE K, Neurohormonal activation in congestive heart failure and the role of vasopressin[J]. Am J Cardiol, 2005, 95 (9A) : 8B-13B.
  • 9THIBONNIER M. Vasopressin receptor antagonists in heart failure [J]. Curr Opin Pharmacol, 2003, 3(6) : 683-687.
  • 10GHEORGHIADE M, NIAZI I, OUYANG J, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial[J]. Circulation, 2003, 107(21): 2690-2696.

共引文献12

同被引文献105

引证文献16

二级引证文献114

国际心血管病杂志
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部